| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2017 | 3-Aroylindoles display antitumor activity in vitro and in vivo: Effects of N1-substituents on biological activity | Lee H.-Y.; Lee J.-F.; Kumar S.; Wu Y.-W.; HuangFu W.-C.; Lai M.-J.; Li Y.-H.; Huang H.-L.; Kuo F.-C.; Hsiao C.-J.; Cheng C.-C.; CHIA-RON YANG ; Liou J.-P. | European Journal of Medicinal Chemistry | 35 | 33 | |
| 2017 | Anti-leukemia effects of the novel synthetic 1-benzylindole derivative 21-900 in vitro and in vivo | Huangfu W.-C.; Chao M.-W.; Cheng C.-C.; Wei Y.-C.; Wu Y.-W.; Liou J.-P.; Hsiao G.; Lee Y.-C.; CHIA-RON YANG | Scientific Reports | 3 | 4 | |
| 2014 | Cell-autonomous heparanase modulates self-renewal and migration in bone marrow-derived mesenchymal stem cells | Cheng C.-C.; Lee Y.-H.; Lin S.-P.; Huangfu W.-C.; I-HSUAN LIU ; SHAU-PING LIN | Journal of Biomedical Science | 14 | 18 | |
| 2017 | Endothelial-derived extracellular matrix ameliorate the stemness deprivation during ex vivo expansion of mouse bone marrow-derived mesenchymal stem cells | Lee M.-K.; Lin S.-P.; HuangFu W.-C.; Yang D.-S.; Liu I.-H.; I-HSUAN LIU ; SHAU-PING LIN | PLoS ONE | 10 | 7 | |
| 2022 | Identification and analysis of a selective DYRK1A inhibitor | Lin T.E.; Chao M.-W.; HuangFu W.-C.; Tu H.-J.; Peng Z.-X.; Su C.-J.; Sung T.-Y.; Hsieh J.-H.; Lee C.-C.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Biomedicine and Pharmacotherapy | 3 | 2 | |
| 2021 | Identification of a dual TAOK1 and MAP4K5 inhibitor using a structure-based virtual screening approach | Chao M.-W.; Lin T.E.; HuangFu W.-C.; Chang C.-D.; Tu H.-J.; Chen L.-C.; Yen S.-C.; Sung T.-Y.; Huang W.-J.; CHIA-RON YANG ; Pan S.-L.; Hsu K.-C. | Journal of Enzyme Inhibition and Medicinal Chemistry | 6 | 6 | |
| 2021 | A novel dual HDAC and HSP90 inhibitor, MPT0G449, downregulates oncogenic pathways in human acute leukemia in vitro and in vivo | Wu Y.-W.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Hsu K.-C.; Liou J.-P.; CHIA-RON YANG ; Yen S.-C.; HuangFu W.-C.; Pan S.-L. | Oncogenesis | 11 | 8 | |
| 2022 | O-methylated flavonol as a multi-kinase inhibitor of leukemogenic kinases exhibits a potential treatment for acute myeloid leukemia | Yen S.-C.; Wu Y.-W.; Huang C.-C.; Chao M.-W.; Tu H.-J.; Chen L.-C.; Lin T.E.; Sung T.-Y.; Tseng H.-J.; Chu J.-C.; Huang W.-J.; CHIA-RON YANG ; HuangFu W.-C.; Pan S.-L.; Hsu K.-C. | Phytomedicine | 4 | 5 | |
| 2017 | An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells | Chao M.-W.; Huang H.-L.; HuangFu W.-C.; Hsu K.-C.; Liu Y.-M.; Wu Y.-W.; Lin C.-F.; Chen Y.-L.; Lai M.-J.; Lee H.-Y.; Liou J.P.; Teng C.-M.; CHIA-RON YANG | Oncotarget | 6 | 5 |
